AB4AD logo

AB4AD
AB4AD (Antibodies for Alzheimer's Disease)

0
Mkt Cap
$152,872.00
24H Volume
$133.62
FDV
$152,872.00
Circ Supply
1M
Total Supply
1M
AB4AD Fundamentals
Max Supply
1M
7D High
$0.1712
7D Low
$0.1529
24H High
$0.00
24H Low
$0.00
All-Time High
$0.3762
All-Time Low
$0.0624
AB4AD Prices
AB4AD / USD
$0.1529
AB4AD / EUR
€0.1309
AB4AD / GBP
£0.1137
AB4AD / CAD
CA$0.2122
AB4AD / AUD
A$0.2283
AB4AD / INR
₹13.75
AB4AD / NGN
NGN 217.98
AB4AD / NZD
NZ$0.2658
AB4AD / PHP
₱9.05
AB4AD / SGD
SGD 0.1963
AB4AD / ZAR
ZAR 2.52
News
all
press releases
<
...
1
>

Sentiment

Indicates whether most users posting on a symbol’s stream over the last 24 hours are fearful or greedy.
0
25
50
75
100
Extreme
Fear
Neutral
Greed
Extreme
Fear
Greed
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

Message Volume

Measures the total amount of chatter on a stream over the last 24 hours.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

Participation Ratio

Measures the number of unique accounts posting on a stream relative to the number of total messages on that stream.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

AboutAb4AD (Antibodies for Alzheimer’s Disease) is a research initiative from Dr. Daniel Z. Bar (Tel Aviv University) that investigates the pathogen hypothesis of Alzheimer’s: common infections (notably herpes and P. gingivalis) appear to modulate AD risk. The team will analyze blood and saliva from dementia-free elderly individuals and compare them to AD patients and younger controls to identify protective antibodies. Instead of only targeting protein aggregation, Ab4AD focuses on why some exposed individuals stay dementia-free, using their natural antibody profiles as blueprints for protection. Funded and tracked through Molecule Catalyst, enabling visible milestones and community governance via IP Tokens (IPTs).
Details
Links
Source
Categories
Base EcosystemDecentralized Science (DeSci)
Date
Market Cap
Volume
Close
January 09, 2026
$152,872.49
$133.62
$0.1529
January 08, 2026
$152,872.49
$133.62
$0.1529
January 08, 2026
$166,075.30
$196.20
$0.1672
January 07, 2026
$166,075.30
$196.20
$0.1672
January 06, 2026
$160,281.78
$271.68
$0.1574
January 05, 2026
$158,701.35
$273.84
$0.1587
January 04, 2026
$158,701.35
$273.84
$0.1587
January 03, 2026
$132,952.60
$20.72
$0.133
January 02, 2026
$133,929.15
$20.88
$0.134
January 01, 2026
$125,516.50
$592.50
$0.1262

Poll

Which crypto category will see the most gains in 2026?
Real World Assets
Privacy Coins
Meme Coins
Other – Comment Below

Latest AB4AD News

Top Discussions

Advertisement|Remove ads.